) The overall objective of the Oral/Head and Neck Oncology Program is to promote interdisciplinary scientific research aimed at reducing the incidence, morbidity, and mortality of oral, head, and neck cancer. The Program brings together a highly interactive group of faculty with common interests from the Schools of Medicine and Dentistry as well as associated faculty at the Veterans Administration Hospital and a network of participating Bay Area dentists. In addition, the Program also promotes collaboration with members of other Cancer Center programs on research including environmental tobacco use and epidemiological studies, molecular carcinogenesis, and developmental strategies for prevention and treatment of oral, head, and neck cancer. The major Program focus is to understand the molecular mechanisms involved in mucosal squamous cell carcinoma progression and invasion/metastasis in order to translate knowledge of basic biology into appropriate treatment modalities. Expertise in tumor marker analysis, growth factor and adhesion receptor function, signal transduction, and molecular genetics is being applied toward research into genetic abnormalities of oral, head, and neck cancer patients and predictive assays of treatment outcomes. Many of the research laboratories in the Program are associated with the NCI/NIDR-funded Oral Cancer Research Center. University of California San Francisco clinical resources in oral, head, and neck cancer include expertise in magnetic resonance spectroscopy, positron emission tomography, skull base surgery, plastic and reconstructive surgery, maxillofacial prosthodontics, intraoperative radiotherapy, three-dimensional conformal intensity modulated radiotherapy, brachytherapy, radiosurgery, and hyperthermia. Clinicians in the Departments of Otolaryngology, Radiation Oncology, Radiology, and Pathology, as well as the Divisions of Medical Oncology and Plastic and Reconstructive Surgery in the School of Medicine, the Departments of Stomatology and Restorative Dentistry in the School of Dentistry, and the Department of Physiological Nursing in the School of Nursing, are collaborating in clinical research on the treatment and prevention of malignancies arising in the head and neck. Members of the Program also are participating in retinoid chemoprevention of second malignancies based on models derived from Radiation Therapy Oncology Group (RTOG) studies of oral, head, and neck cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA082103-02
Application #
6348995
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2000-08-01
Project End
2001-07-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Ryu, Jae Kyu; Rafalski, Victoria A; Meyer-Franke, Anke et al. (2018) Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. Nat Immunol 19:1212-1223
Zhou, Yu; Zou, Hao; Yau, Christina et al. (2018) Discovery of internalizing antibodies to basal breast cancer cells. Protein Eng Des Sel 31:17-28
Tat, David; Kenfield, Stacey A; Cowan, Janet E et al. (2018) Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSUREā„¢). Prostate 78:32-39
Guydish, Joseph; Tajima, Barbara; Le, Thao et al. (2018) Do cigarette graphic warnings encourage smokers to attend a smoking cessation programme: a quasi-experimental study. Tob Control 27:43-49
Dvorak, Christopher C; Satwani, Prakash; Stieglitz, Elliot et al. (2018) Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. Pediatr Blood Cancer 65:e27034
Fan, Qi Wen; Nicolaides, Theodore P; Weiss, William A (2018) Inhibiting 4EBP1 in Glioblastoma. Clin Cancer Res 24:14-21
Sannino, Sara; Guerriero, Christopher J; Sabnis, Amit J et al. (2018) Compensatory increases of select proteostasis networks after Hsp70 inhibition in cancer cells. J Cell Sci 131:
Lam, Christine; Ferguson, Ian D; Mariano, Margarette C et al. (2018) Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment. Haematologica 103:1218-1228
Truillet, Charles; Parker, Matthew F L; Huynh, Loc T et al. (2018) Measuring glucocorticoid receptor expression in vivo with PET. Oncotarget 9:20399-20408
Phillips, Kathryn A; Trosman, Julia R; Deverka, Patricia A et al. (2018) Insurance coverage for genomic tests. Science 360:278-279

Showing the most recent 10 out of 192 publications